Clinical Trials Directory

Trials / Terminated

TerminatedNCT04577131

Improving Adherence to Home Blood Pressure Monitoring With Pharmacist Support

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to evaluate the impact of monitoring blood pressure from home everyday with pharmacist support.

Detailed description

High blood pressure is very common and increases risk of heart, kidney, brain, and eye disease. It is important to diagnose and treat high blood pressure to reduce risk of these complications. Getting blood pressure checked only when someone sees a doctor is not the best way to diagnose high blood pressure or to make sure blood pressure is well managed. Checking blood pressure at home gives a better idea of whether someone's blood pressure is normal or too high. As part of their usual blood pressure monitoring, participants will be given an Omron 3 series or 5 series blood pressure monitor which has been cleared by the US Food and Drug Administration and validated to meet accuracy and performance requirements. For one month, participants will monitor their blood pressure once a day and then return the device to the clinic at the end of the study. Participants will text their blood pressure result to the American Heart Association's Check, Change, Control (CCC) secure online tracker. As part of the research study, participants will also be randomized to either receive or not receive weekly check-in phone calls from a pharmacist to review their blood pressures and the number of times they tested in that week. Approximately 50 individuals will participate in this study. Participation in this study will last 1 month.

Conditions

Interventions

TypeNameDescription
BEHAVIORALWeekly check-inWeekly check-in phone calls from a pharmacist to review blood pressures and the number of times tested in that week

Timeline

Start date
2020-11-05
Primary completion
2020-11-05
Completion
2020-11-05
First posted
2020-10-06
Last updated
2021-01-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04577131. Inclusion in this directory is not an endorsement.